文献速递主动脉疾病

肾下腹主动脉瘤EVAR同期行髂内动脉栓塞的预后影响

Implications of concomitant hypogastric artery embolization with endovascular repair of infrarenal abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2017-02-16

基于2011-2014年ACS NSQIP数据库5881例肾下腹主动脉瘤EVAR患者,387例(6.6%)同期行髂内动脉栓塞(HAE+EVAR)。HAE+EVAR组缺血性结肠炎(2.6% vs 0.9%)、需透析肾衰竭(2.8% vs 1%)、肺炎(2.6% vs 1.3%)及围术期输血(17% vs 13%)发生率更高,30天死亡率4.1% vs 2.5%(P=.044);HAE独立增加结肠缺血(aOR 2.98)和需透析肾衰竭(aOR 2.22)风险,但非死亡独立预测因子。

要点

  • HAE+EVAR与更高的缺血性结肠炎和需透析肾衰竭风险独立相关。
  • HAE+EVAR组30天死亡率4.1%,高于单纯EVAR的2.5%(P=.044)。
  • HAE并非30天死亡的独立预测因子,但住院时间更长。

核心结论

  • EVAR同期行髂内动脉栓塞与更长且更复杂的住院过程相关。
  • HAE增加缺血性结肠炎和需透析肾衰竭的风险,但非死亡的独立预测因子。

研究设计与样本

  • 回顾性队列研究,查询ACS NSQIP数据库2011至2014年数据。
  • 共纳入5881例肾下腹主动脉瘤EVAR患者,其中387例(6.6%)行HAE+EVAR。
  • 采用多因素分析确定HAE+EVAR患者发生显著并发症的术前和术中因素。

主要发现

  • HAE+EVAR组缺血性结肠炎发生率2.6%,EVAR组0.9%(P=.002)。
  • HAE+EVAR组需透析肾衰竭发生率2.8%,EVAR组1%(P=.001)。
  • HAE+EVAR组肺炎发生率2.6%,EVAR组1.3%(P=.039)。
  • HAE+EVAR组围术期输血率17%,EVAR组13%(P=.024)。
  • HAE+EVAR组30天死亡率4.1%,EVAR组2.5%(P=.044);两组血栓栓塞事件、卒中、心肌梗死、下肢缺血、再手术和再入院率无显著差异(P>.05)。

临床怎么用

  • EVAR术中应重视髂内动脉保留,以降低缺血性结肠炎和肾衰竭风险。
  • 对需行HAE的患者,应警惕术后缺血性结肠炎和需透析肾衰竭,加强监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypogastric artery embolization (HAE) is associated with significant risk of ischemic complications. We assessed the impact of HAE on 30-day outcomes of endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic aneurysms. METHODS: We queried the American College of Surgeons National Surgical Quality Improvement Program database from 2011 to 2014 to identify and to compare clinical features, operative details, and 30-day outcomes of EVAR with those of concomitant HAE with EVAR (HAE + EVAR). Multivariate analysis was performed to determine preoperative and intraoperative factors associated with development of significant complications observed in patients with HAE + EVAR. RESULTS: In a cohort of 5881 patients, 387 (6.6%) underwent HAE + EVAR. Compared with EVAR, a higher incidence of ischemic colitis (2.6% vs 0.9%; P = .002), renal failure requiring dialysis (2.8% vs 1%; P = .001), pneumonia (2.6% vs 1.3%; P = .039), and perioperative blood transfusion (17% vs 13%; P = .024) was noted after HAE + EVAR. Thirty-day thromboembolic events, strokes, myocardial infarction, lower extremity ischemia, reoperation, and readmission rates were not significantly different (P > .05). Mortality at 30 days in HAE + EVAR patients was 4.1% compared with 2.5% with EVAR (P = .044). HAE was independently associated with increased risk of colonic ischemia (adjusted odds ratio, 2.98; 95% confidence interval, 1.44-6.14; P = .003) and renal failure requiring dialysis (adjusted odds ratio, 2.22; 95% confidence interval, 1.09-4.53; P = .029). However, HAE was not an independent predictor of mortality. Average length of hospital stay was 4 ± 8.5 days after HAE + EVAR vs 3.3 ± 5.9 days after EVAR (P = .001). CONCLUSIONS: Concomitant HAE with EVAR is associated with longer and more complicated hospital stays. Ischemic colitis is a rare complication of EVAR. HAE increases the risk of ischemic colitis and renal failure requiring dialysis. This study highlights the importance of hypogastric artery preservation during EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Farivar BS, Kalsi R, Drucker CB, et al. Implications of concomitant hypogastric artery embolization with endovascular repair of infrarenal abdominal aortic aneurysms. J Vasc Surg. 2017. PMID: 28216366. doi:10.1016/j.jvs.2016.10.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。